Your browser doesn't support javascript.
loading
Efficacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: a multicenter, prospective, single-arm, phase 2 trial.
Fu, Wei-Jun; Wang, Ya-Fei; Zhao, Hong-Guo; Niu, Ting; Fang, Bai-Jun; Liao, Ai-Jun; Bai, Hai; Lu, Jin.
Afiliación
  • Fu WJ; Department of Hematology, Changzheng Hospital, Shanghai, China.
  • Wang YF; Department of Hematology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Zhao HG; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Niu T; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.
  • Fang BJ; Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Liao AJ; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Bai H; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Lu J; Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, China.
BMC Cancer ; 22(1): 722, 2022 Jul 01.
Article en En | MEDLINE | ID: mdl-35778685

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucopenia / Mieloma Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucopenia / Mieloma Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China
...